EP1229930A4 - Compositions and methods for treatment of allergic disorders - Google Patents
Compositions and methods for treatment of allergic disordersInfo
- Publication number
- EP1229930A4 EP1229930A4 EP00975685A EP00975685A EP1229930A4 EP 1229930 A4 EP1229930 A4 EP 1229930A4 EP 00975685 A EP00975685 A EP 00975685A EP 00975685 A EP00975685 A EP 00975685A EP 1229930 A4 EP1229930 A4 EP 1229930A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- compositions
- treatment
- methods
- allergic disorders
- allergic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000000172 allergic effect Effects 0.000 title 1
- 208000010668 atopic eczema Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6869—Interleukin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/07—Bacillus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6866—Interferon
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/335—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Lactobacillus (G)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPQ415899 | 1999-11-19 | ||
AUPQ4158A AUPQ415899A0 (en) | 1999-11-19 | 1999-11-19 | Compositions for and methods of treatment of allergic diseases |
PCT/AU2000/001414 WO2001037865A1 (en) | 1999-11-19 | 2000-11-20 | Compositions and methods for treatment of allergic disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1229930A1 EP1229930A1 (en) | 2002-08-14 |
EP1229930A4 true EP1229930A4 (en) | 2004-09-22 |
Family
ID=3818302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00975685A Withdrawn EP1229930A4 (en) | 1999-11-19 | 2000-11-20 | Compositions and methods for treatment of allergic disorders |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1229930A4 (en) |
JP (1) | JP2003514869A (en) |
KR (1) | KR20020084066A (en) |
CN (1) | CN1391480A (en) |
AU (1) | AUPQ415899A0 (en) |
BR (1) | BR0015698A (en) |
CA (1) | CA2391499A1 (en) |
HK (1) | HK1049115A1 (en) |
WO (1) | WO2001037865A1 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ID29150A (en) | 1999-01-15 | 2001-08-02 | Entpr Ireland Cs | USE OF LACTOBACILLUS SALIVARIUS |
FI110668B (en) * | 2000-06-20 | 2003-03-14 | Aboatech Ab Oy | Use of probiotics for primary prevention of atopic diseases |
PE20030283A1 (en) * | 2001-07-26 | 2003-05-01 | Alimentary Health Ltd | LACTOBACILLUS CASEI STRAINS |
GB0124580D0 (en) | 2001-10-12 | 2001-12-05 | Univ Reading | New composition |
JP4212838B2 (en) | 2002-06-26 | 2009-01-21 | カルピス株式会社 | Antiallergic agent |
US20060088513A1 (en) * | 2003-03-13 | 2006-04-27 | Kirin Beer Kabushiki Kaisha | Antiallergic composition |
JP4712289B2 (en) * | 2003-08-26 | 2011-06-29 | 株式会社エイ・エル・エイ | Immune promoting composition |
JP4591810B2 (en) * | 2003-09-19 | 2010-12-01 | 日之出産業株式会社 | Nasal composition for controlling hay fever allergic rhinitis |
RU2407784C2 (en) * | 2003-12-17 | 2010-12-27 | Н.В. Нютрисиа | Probiotic strain lactobacillus casei producing lactic acid, application of strain for preparing nutritinal composition for treatment or prevention of pulmonary dysfunction, nutritinal composition and method for preparing thereof, drug for treatment or prevention of chronic obstructive pulmonary disease in individual and application of strain for preparing drug, container |
US7955834B2 (en) | 2004-06-03 | 2011-06-07 | Biogaia Ab | Method for improved breast milk feeding to reduce the risk of allergy |
TWI356680B (en) * | 2007-01-05 | 2012-01-21 | Promd Biotech Co Ltd | Anti-allergy lactic acid bacteria |
CN102657260B (en) * | 2007-06-21 | 2013-08-21 | 东宇生物科技股份有限公司 | Antiallergic lactobacillus |
CN101328468B (en) * | 2007-06-21 | 2012-05-23 | 东宇生物科技股份有限公司 | Antiallergic lactic acid bacteria |
EP2065048A1 (en) * | 2007-11-30 | 2009-06-03 | Institut Pasteur | Use of a L. casei strain, for the preparation of a composition for inhibiting mast cell activation |
DK2244734T3 (en) | 2008-02-01 | 2016-08-15 | Murdoch Childrens Res Inst | PROCEDURE FOR INDUCTION OF TOLERANCE ABOUT AN ALLERGY |
CN103282028B (en) | 2010-08-10 | 2016-04-27 | R·P·舍勒科技有限责任公司 | The method of the stable Gelseal of preparation containing microencapsulation probiotic bacteria |
KR101311989B1 (en) * | 2010-11-17 | 2013-09-26 | 주식회사한국야쿠르트 | Products containing Lactobacillus casei HY7211 having immuno-regulatory and immuno-stimulatory functions as effective component |
AU2019206205A1 (en) * | 2018-01-12 | 2020-06-25 | Gi Innovation, Inc. | Composition comprising probiotics and polypeptide having binding affinity for IgE and use thereof |
CN111296842B (en) * | 2020-02-14 | 2021-01-05 | 赵一鸣 | Probiotic composition with anti-allergy effect |
CN112375722B (en) * | 2021-01-18 | 2021-04-13 | 山东中科嘉亿生物工程有限公司 | Lactobacillus casei LC-12 for improving allergy, and product and application thereof |
CN117085046A (en) * | 2023-10-20 | 2023-11-21 | 潍坊君薇生物科技有限责任公司 | Lactobacillus acidophilus LS001 metaplasia and application thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5946488B2 (en) | 1978-08-07 | 1984-11-13 | 極東脂肪酸株式会社 | Allergic reaction inhibitor |
JPS5946491B2 (en) | 1979-03-14 | 1984-11-13 | 極東脂肪酸株式会社 | Asthma treatment agent |
JPH07265064A (en) | 1993-11-23 | 1995-10-17 | Taketoshi Yamada | Composition for improving enterobacterial flora |
JPH092959A (en) * | 1995-06-16 | 1997-01-07 | Yakult Honsha Co Ltd | Immuno-globulin e antibody production suppressant and antiallergic agent |
EP0904784A1 (en) * | 1997-09-22 | 1999-03-31 | N.V. Nutricia | Probiotic nutritional preparation |
JPH11199495A (en) * | 1998-01-10 | 1999-07-27 | Nichinichi Seiyaku Kk | Antiallergic agent using enteric capsule |
IT1298918B1 (en) * | 1998-02-20 | 2000-02-07 | Mendes Srl | USE OF ARGININE DEIMINASE BACTERIA TO INDUCE APOPTOSIS AND / OR REDUCE AN INFLAMMATORY REACTION AND PHARMACEUTICAL COMPOSITIONS |
JP4074006B2 (en) * | 1998-06-24 | 2008-04-09 | アサマ化成株式会社 | Method for producing IgE antibody production inhibitor and food using the same |
-
1999
- 1999-11-19 AU AUPQ4158A patent/AUPQ415899A0/en not_active Abandoned
-
2000
- 2000-11-20 CA CA002391499A patent/CA2391499A1/en not_active Abandoned
- 2000-11-20 BR BR0015698-1A patent/BR0015698A/en not_active IP Right Cessation
- 2000-11-20 WO PCT/AU2000/001414 patent/WO2001037865A1/en active Search and Examination
- 2000-11-20 EP EP00975685A patent/EP1229930A4/en not_active Withdrawn
- 2000-11-20 JP JP2001539479A patent/JP2003514869A/en not_active Withdrawn
- 2000-11-20 KR KR1020027006409A patent/KR20020084066A/en not_active Application Discontinuation
- 2000-11-20 CN CN00815855A patent/CN1391480A/en active Pending
-
2003
- 2003-02-11 HK HK03100999.8A patent/HK1049115A1/en unknown
Non-Patent Citations (1)
Title |
---|
No further relevant documents disclosed * |
Also Published As
Publication number | Publication date |
---|---|
BR0015698A (en) | 2002-07-23 |
KR20020084066A (en) | 2002-11-04 |
WO2001037865A1 (en) | 2001-05-31 |
CN1391480A (en) | 2003-01-15 |
JP2003514869A (en) | 2003-04-22 |
EP1229930A1 (en) | 2002-08-14 |
CA2391499A1 (en) | 2001-05-31 |
HK1049115A1 (en) | 2003-05-02 |
AUPQ415899A0 (en) | 1999-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1049115A1 (en) | Compositions and methods for treatment of allergic disorders | |
EP1227821A4 (en) | Therapeutic compositions and methods of use thereof | |
AU6919100A (en) | Compositions including modafinil for treatment of eating disorders and for appetite stimulation | |
IL162153A0 (en) | Methods and compositions for treatment of central nervous systemdisorders | |
NZ514044A (en) | Herbal compositions and uses for the treatment of allergic reactions | |
EP1335736A4 (en) | Compositions and methods for diagnosis and treatment of cardiovascular disorders | |
HUP0302718A3 (en) | Methods and compositions for the treatment of diseases of the eye | |
PL373565A1 (en) | Methods and compositions for treatment of immune dysfunction disorders | |
AU2002362115A8 (en) | Composition and methods for treatment of neurological disorders | |
AU1953701A (en) | Methods and compositions for treatment of inflammatory disease | |
EP1539100A4 (en) | Composition and methods for the treatment of skin disorders | |
EP1440080A4 (en) | Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750 | |
IL151403A0 (en) | Compositions and methods for treatment of epilepsy | |
EP1315499A4 (en) | Compositions and methods for the treatment of anorectal disorders | |
HUP0200466A3 (en) | Lipoglycan compositions and methods of treating parasitic infections | |
AU2002348324A1 (en) | Methods and compositions for the treatment and diagnosis of pain disorders using 46566 | |
AU3924500A (en) | Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine | |
EP1440165A4 (en) | Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943 | |
AU1361201A (en) | Methods and compositions for treatment of traumatic brain injury | |
AU1621501A (en) | Methods and compositions for treatment of disease | |
AU2002360318A1 (en) | Methods and compositions for the treatment and diagnosis of pain disorders using 9805 | |
EP1210094A4 (en) | Herbal compositions and uses for the treatment of allergic reactions | |
AU2001263047A1 (en) | Compositions and methods for treatment of proliferative disorders | |
EP1463832A4 (en) | Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 86604 | |
EP1439851A4 (en) | Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 54394 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20020610 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20040811 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: DSM IP ASSETS B.V. |
|
TPAC | Observations filed by third parties |
Free format text: ORIGINAL CODE: EPIDOSNTIPA |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20061229 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1049115 Country of ref document: HK |